All In MedTech

Device Trial Radar · NCT06865755

Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication

Deploying and Evaluating a Technology Based System to Help People Adhere to Long Term Medications

Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
San Diego State UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Virginia; National Cancer Institute (NCI)
First posted
Mar 10, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
Female only, from 21 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to learn about the impact of an integrated medication monitoring system in breast cancer survivors aged 21-70 who are prescribed endocrine therapy. The main question it aims to address is: Does the integrated medication monitoring system improve medication adherence among breast cancer survivors when used over a six-month period? Fifteen English-speaking breast cancer survivors who meet the inclusion criteria will use a combination of smartphone-based ecological momentary assessments, a medication event monitoring system (Wisepill), and a wearable sensor (Fitbit). After 2 months, participants will be provided personalized content to facilitate medication adherence through an app (Digital Trails) and through WisePill. Participants will complete online surveys at baseline, 3 months, and 6 months to assess their experiences and adherence.

Conditions

  • Breast Cancer Survivor
  • Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Interventions

  • integrated medication monitoring (MM) systemDevice

    We have created a new integrated medication monitoring (MM) system consisting of baseline, 3-month, and 6-month surveys, smartphone-based ecological momentary assessment via an application installed on a smartphone (Digital Trails based on the UVA Sensus app), a wireless medication event monitoring system device (MEMS; Wisepill), and a wearable sensor (Fitbit), and data collected passively from smartphone sensors using the Digital Trails app. These sources of information will be used to understand predictors of medication taking behaviors and, after two months of monitoring, to deploy appropriate interventions which will be delivered via the Digital Trails app platform.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Wisepill MEMS Sensor data collectionTime frame: From enrollment to the end of study at 6 months

25 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • San Diego State University

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.